IE56205B1 - Steroid compounds - Google Patents

Steroid compounds

Info

Publication number
IE56205B1
IE56205B1 IE2563/83A IE256383A IE56205B1 IE 56205 B1 IE56205 B1 IE 56205B1 IE 2563/83 A IE2563/83 A IE 2563/83A IE 256383 A IE256383 A IE 256383A IE 56205 B1 IE56205 B1 IE 56205B1
Authority
IE
Ireland
Prior art keywords
particles
compound
particulate
compound according
hydrogen
Prior art date
Application number
IE2563/83A
Other languages
English (en)
Other versions
IE832563L (en
Original Assignee
Sterwin Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin Ag filed Critical Sterwin Ag
Publication of IE832563L publication Critical patent/IE832563L/en
Publication of IE56205B1 publication Critical patent/IE56205B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
IE2563/83A 1982-11-02 1983-11-02 Steroid compounds IE56205B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8231278 1982-11-02

Publications (2)

Publication Number Publication Date
IE832563L IE832563L (en) 1984-05-02
IE56205B1 true IE56205B1 (en) 1991-05-22

Family

ID=10533991

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2563/83A IE56205B1 (en) 1982-11-02 1983-11-02 Steroid compounds

Country Status (12)

Country Link
EP (1) EP0108606B1 (Direct)
JP (1) JPS5995300A (Direct)
AT (1) ATE38236T1 (Direct)
DE (1) DE3378318D1 (Direct)
DK (1) DK499683A (Direct)
ES (1) ES8504486A1 (Direct)
FI (1) FI834025L (Direct)
GB (1) GB2130588B (Direct)
GR (1) GR79688B (Direct)
IE (1) IE56205B1 (Direct)
NO (1) NO833976L (Direct)
PT (1) PT77593B (Direct)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
CN103169714A (zh) 2005-07-12 2013-06-26 Dmi生物科学公司 治疗疾病的方法和产品
GB2627797A (en) * 2023-03-02 2024-09-04 Norbrook Lab Ltd Trilostane formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
GB1123770A (en) * 1966-11-15 1968-08-14 Sterling Drug Inc 2-cyano-3-oxo-steroids
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
US4160027A (en) * 1977-12-20 1979-07-03 Sterling Drug Inc. Steroid cyanoketones and intermediates
GB8328929D0 (en) 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds

Also Published As

Publication number Publication date
GB2130588A (en) 1984-06-06
JPS5995300A (ja) 1984-06-01
EP0108606A1 (en) 1984-05-16
DK499683D0 (da) 1983-11-01
FI834025A7 (fi) 1984-05-03
PT77593A (en) 1983-12-01
IE832563L (en) 1984-05-02
DE3378318D1 (en) 1988-12-01
GB2130588B (en) 1986-08-13
FI834025L (fi) 1984-05-03
ES526874A0 (es) 1985-05-01
EP0108606B1 (en) 1988-10-26
PT77593B (en) 1986-03-18
DK499683A (da) 1984-05-03
FI834025A0 (fi) 1983-11-02
ATE38236T1 (de) 1988-11-15
GR79688B (Direct) 1984-10-31
NO833976L (no) 1984-05-03
GB8329173D0 (en) 1983-12-07
JPH0443078B2 (Direct) 1992-07-15
ES8504486A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
EP0037740B1 (en) Solid microdose drug preparation
DE69908021T2 (de) Ziprasidonhaltige Arzneimittel
SU1535369A3 (ru) Способ получени твердой фармацевтической композиции пролонгированного действи
US4517179A (en) Rapid dissolving, uniform drug compositions and their preparation
DE69929411T2 (de) Verfahren zur Herstellung dispergierbarer Sterol- und Stanolverbindungen
DE60010089T2 (de) Beta-carbolin arzneistoffprodukte
HUP0401935A2 (hu) Mikronizált progeszterontartalmú gyógyszerészeti készítmény, eljárás előállítására és alkalmazásai
Eisa et al. Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
US3966899A (en) Method of treatment of medicines
WO1997047290A1 (en) Liquisolid systems and methods of preparing same
DE3520184A1 (de) Neue galenische retardform
BR112014027087B1 (pt) tablete e método para fabricação de um tablete de mesilato de bromocriptina
IE56205B1 (en) Steroid compounds
UA57596C2 (uk) Похідне бензотіофену, фармацевтична лікарська форма, фармацевтична композиція, спосіб лікування остеопорозу та спосіб зниження рівнів ліпідів
CN108066312B (zh) 一种帕博西尼药物组合物及其制备方法
EP0064388B1 (en) Retard oral pharmaceutical compositions
DE69325996T2 (de) Aminoguanidin-spruehtrocknungsverfahren
Rajeswari et al. Formulation and evaluation of Famotidine fast dissolving tablets using synthetic superdisintegrants
Sarfaraz et al. Factorial Design Based Optimization of Hydroxyzine Hydrochloride Fast Dissolving Tablets.
Selvamuthukumar et al. Formulation development and evaluation of immediate release tablet of terbinafine hydrochloride
Gaikwad et al. Development of controlled release spheroids using Buchanania cochinchinesis gum
Mehta et al. Investigations of Plantago ovata husk powder as a disintegrating agent for development of famotidine tablets
Kumar et al. Preparation, evaluation & optimization of nanoparticles composed of pyridostigmine
Jadhav et al. Liquisolid technique a novel approach to enhance solubility and dissolution rate: a review
Rani Design and Evaluation of Ezetimibe rapidmelts by direct compression and sublimation methods

Legal Events

Date Code Title Description
MM4A Patent lapsed